FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to cardiology. In patients over 60 years old, being on chronic haemodialysis for at least 12 months according to scheme 2/2/3, daily ECG monitoring is performed with counting the number of supraventricular extrasystoles, EchoCG data is used to determine a left ventricular mass index and a left ventricular ejection fraction by Simson's technique. If according to the daily ECG monitoring the number of supraventricular extrasystoles is more than 70 per hour, according to the EchoCG, the left ventricular mass index is more than 119 g/m2, the left ventricular ejection fraction according to Simpson's technique is less than 49%, the development of supraventricular cardiac rhythm disturbances in the patient is predicted atrial fibrillation.
EFFECT: method makes it possible to increase accuracy of AF prediction, to select a priority group of patients with chronic kidney disease and cardiac rhythm disturbances for dispensary observation and prescription of personalized treatment, which will ensure the prescription of an adequate therapy to prevent AF and reduce the number of fatal outcomes.
1 cl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF PREDICTION THE RECURRENCE OF FIBRILLATION OF PRECURITIES FOR REMOTE TIMES AFTER OPERATION OF RADIO FREQUENCY ABLATION OF PULMONARY VEIN ENTRANCES FOR PATIENTS WITH FRONT-REAR SIZE OF LEFT ATRIUM NOT MORE THAN 5 CM | 2017 |
|
RU2644939C1 |
| METHOD FOR PREDICTING POSITIVE RESPONSE TO CARDIAC CONTRACTILITY MODULATION THERAPY IN PATIENTS WITH CHRONIC HEART FAILURE WITH REDUCED LEFT VENTRICULAR EJECTION FRACTION AND ATRIAL FIBRILLATION | 2023 |
|
RU2807230C1 |
| METHOD FOR PREDICTION OF CARDIOTOXICITY OF CHEMO- AND TARGETED THERAPY USING ECHOCARDIOGRAPHIC DIAGNOSTICS | 2023 |
|
RU2828824C1 |
| METHOD FOR PREDICTING THE DEVELOPMENT OF LIFE-THREATENING VENTRICULAR ARRHYTHMIAS AND SUDDEN CARDIAC DEATH IN PATIENTS WITH CORONARY HEART DISEASE AND HEART FAILURE WITH A REDUCED EJECTION FRACTION WITHIN 12 MONTHS AFTER IMPLANTATION OF A CARDIOVERTER DEFIBRILLATOR | 2021 |
|
RU2758120C1 |
| PREDICTION METHOD OF HIGH-GRADE VENTRICULAR ARRHYTHMIA IN PATIENTS WITH CHRONIC HEART FAILURE AND PRESERVED LEFT VENTRICULAR EJECTION FRACTION | 2017 |
|
RU2645958C1 |
| METHOD FOR PREOPERATIVE PREDICTION OF THE RISK OF LATE RECURRENCE OF ATRIAL FIBRILLATION AFTER THE PRIMARY PROCEDURE OF ENDOCARDIAL RADIOFREQUENCY ABLATION | 2021 |
|
RU2767133C1 |
| METHOD FOR PREDICTING RISK OF ATRIAL FIBRILLATION DEVELOPMENT IN THE ABSENCE OF STRUCTURAL AND VALVE HEART PATHOLOGY OF PERSONS WITH NORMAL LEFT ATRIUM SIZES | 2017 |
|
RU2644936C1 |
| METHOD OF DETERMINING OPERABILITY OF PATIENTS SUFFERING OESOPHAGEAL CANCER | 2019 |
|
RU2718290C1 |
| METHOD FOR PREDICTION OF ATRIAL FIBRILLATION DEVELOPMENT IN PATIENTS WITH OBSTRUCTIVE SLEEP APNEA SYNDROME | 2022 |
|
RU2793677C1 |
| METHOD FOR DETERMINING THROMBOSIS OF LEFT ATRIAL APPENDAGE ACCORDING TO CONTRAST TRANSTHORACIC ECHOCARDIOGRAPHY | 2019 |
|
RU2723391C1 |
